Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 1/20 | 0.37 |
| ▸ | SOD1 | P00441 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 3/20 | 0.34 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.34 |
| ▸ | RELA | Q04206 | 1/20 | 0.34 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.34 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.34 |
| ▸ | PTPRC | P08575 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butane SCHEMBL5300026 | 0.84 | IDO1 (0.49) | — | |
| Butane SCHEMBL5292210 | 0.83 | IDO1 (0.53) | MRGPRX4 | |
| Butane SCHEMBL1238313 | 0.82 | ALDH1A1 (0.46) | TSHRMAPK1TDP1L3MBTL1TP53 | |
| SCHEMBL9849212 | 0.79 | CYP4F2 (0.36) | TSHRF2MRGPRX4PTPRCPTPN1 | |
| SCHEMBL9849186 | 0.78 | TAAR1 (0.55) | SMN1; SMN2 | |
| SCHEMBL8507775 | 0.77 | IDO1 (0.57) | MRGPRX4 | |
| SCHEMBL3993950 | 0.76 | LOXL2 (0.60) | SMN1; SMN2TSHRMAPTMRGPRX4 | |
| SCHEMBL27370550 | 0.76 | IDO1 (0.55) | MRGPRX4 | |
| SCHEMBL29149475 | 0.76 | IDO1 (0.55) | — | |
| SCHEMBL27850575 | 0.76 | CYP19A1 (0.47) | TDP1MRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007005172-A1 | METHOD FOR THE PREPARATION OF ARALKYL DIALKYL PHOSPHONATES | FERRO CORPORATION (US) | 2007-01-11 | — | — | WO | disclosed |
| US-20070004833-A1 | METHOD FOR THE PREPARATION OF ARALKYL DIALKYL PHOSPHONATES | FERRO CORPORATION (US) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004833-A1 | METHOD FOR THE PREPARATION OF ARALKYL DIALKYL PHOSPHONATES | ADK, ARAF, RPN1 | BCL2 4236/4885SOD1 4094/4885MGLL 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.